Trial Profile
Effects of DAPAgliflozin on Cardiopulmonary Exercise Capacity and Hemodynamics in Pulmonary Arterial Hypertension: A Double Blind Randomized Trial. (DAPAH-trial)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2023
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms DAPAH; DAPAH-trial
- 28 Mar 2023 Status changed from not yet recruiting to recruiting.
- 24 Oct 2022 Planned initiation date changed from 1 Jun 2022 to 1 Jan 2023.
- 07 Jan 2022 New trial record